» Articles » PMID: 37892335

Clinical Management and Therapy of Precocious Puberty in the Sapienza University Pediatrics Hospital of Rome, Italy

Abstract

Puberty identifies the transition from childhood to adulthood. Precocious puberty is the onset of signs of pubertal development before age eight in girls and before age nine in boys, it has an incidence of 1/5000-1/10,000 with an F:M ratio ranging from 3:1 to 20:1. Precocious puberty can be divided into central, also known as gonadotropin-dependent precocious puberty or true precocious puberty, and peripheral, also recognized as gonadotropin-independent precocious puberty or precocious pseudopuberty. Thus, the main aim of this narrative report is to describe the standard clinical management and therapy of precocious puberty according to the experience and expertise of pediatricians and pediatric endocrinologists at Policlinico Umberto I, Sapienza University of Rome, Italy. In the suspicion of early sexual maturation, it is important to collect information regarding the age of onset, the speed of maturation of secondary sexual features, exposure to exogenous sex steroids and the presence of neurological symptoms. The objective examination, in addition to the evaluation of secondary sexual characteristics, must also include the evaluation of auxological parameters. Initial laboratory investigations should include serum gonadotropin levels (LH and FSH) and serum levels of the sex steroids. Brain MRI should be performed as indicated by the 2009 Consensus Statement in all boys regardless of chronological age and in all girls with onset of pubertal signs before 6 years of age. The gold standard in the treatment of central precocious puberty is represented by GnRH analogs, whereas, as far as peripheral forms are concerned, the triggering cause must be identified and treated. At the moment there are no reliable data establishing the criteria for discontinuation of GnRH analog therapy. However, numerous pieces of evidence suggest that the therapy should be suspended at the physiological age at which puberty occurs.

Citing Articles

Endometriosis in Adolescence: A Narrative Review of the Psychological and Clinical Implications.

Panvino F, Paparella R, Pisani F, Tarani F, Ferraguti G, Fiore M Diagnostics (Basel). 2025; 15(5).

PMID: 40075795 PMC: 11898908. DOI: 10.3390/diagnostics15050548.


Inflammation and oxidative stress processes in induced precocious puberty in rats.

Pop R, Gherman L, Jianu E, Rosian S, Onofrei M, Mocan L Heliyon. 2025; 10(24):e40962.

PMID: 39759285 PMC: 11699080. DOI: 10.1016/j.heliyon.2024.e40962.


Assessing Psychiatric Evaluations in Premature Thelarche and Idiopathic Central Precocious Puberty Cases: Exploring Depression, Anxiety, Quality of Life, and Coping Challenges.

Donbaloglu Z, Bostan R Cureus. 2024; 16(8):e68123.

PMID: 39347161 PMC: 11438484. DOI: 10.7759/cureus.68123.

References
1.
Lewis K, Lee P . Endocrinology of male puberty. Curr Opin Endocrinol Diabetes Obes. 2008; 16(1):5-9. DOI: 10.1097/MED.0b013e32832029be. View

2.
Tenuta M, Carlomagno F, Cangiano B, Kanakis G, Pozza C, Sbardella E . Somatotropic-Testicular Axis: A crosstalk between GH/IGF-I and gonadal hormones during development, transition, and adult age. Andrology. 2020; 9(1):168-184. DOI: 10.1111/andr.12918. View

3.
Papanikolaou A, Michala L . Autonomous Ovarian Cysts in Prepubertal Girls. How Aggressive Should We Be? A Review of the Literature. J Pediatr Adolesc Gynecol. 2015; 28(5):292-6. DOI: 10.1016/j.jpag.2015.05.004. View

4.
Brito V, Canton A, Seraphim C, Abreu A, Macedo D, Mendonca B . The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty. Endocr Rev. 2022; 44(2):193-221. PMC: 9985412. DOI: 10.1210/endrev/bnac020. View

5.
Shim Y, Lee H, Hwang J . Genetic factors in precocious puberty. Clin Exp Pediatr. 2021; 65(4):172-181. PMC: 8990949. DOI: 10.3345/cep.2021.00521. View